Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolic Effects of Melatonin in Patients Treated With Second Generation Antipsychotics

NCT01811160 is registered in ClinicalTrials.gov with Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente as lead sponsor.

NCT NCT01811160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01811160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolic Effects of Melatonin in Patients Treated With Second Generation Antipsychotics
Lead sponsor
Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2008
Completion date
November 30, 2011
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

second generation antipsychotic induced metabolic adverse effects